Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix
CA 2366852 A1 · Owner: Scasso, Alejandro Fabio · Inventors: Scasso, Alejandro Fabio; Stefano, Francisco Jose Evaristo; Gabach, Roberto Juan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention pertains to transdermal administration devices and more , particularly, to transdermal administration devices that contain: (a) a pharmaceutical composition for the systemic administration of a NSAID; (b) a backing layer; and, (c) a release liner; wherein said pharmaceutical composition includes at least one component that enhances percutaneous permeation selected from: (i) fatty alcohols (C4-C30); (ii) mono di or , triglyceryl fatty acid esters (C4-C30); and (iii) fatty acid esters (C4-C30); , and a pressure sensitive acrylic adhesive matrix formed by a copolymer with polar functional groups in which the NSAID is incorporated.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 29, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 29, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 1, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.